4D MOLECULAR THERAPEUTICS IN's ticker is FDMT and the CUSIP is 35104E100.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,290,807 | -31.6% | 258,508 | -2.8% | 0.00% | 0.0% |
| Q2 2023 | $4,808,011 | +28.2% | 266,077 | +22.0% | 0.00% | 0.0% |
| Q1 2023 | $3,749,242 | -22.2% | 218,106 | +0.6% | 0.00% | -50.0% |
| Q4 2022 | $4,817,349 | +184.0% | 216,900 | +2.8% | 0.00% | +100.0% |
| Q3 2022 | $1,696,000 | +37.9% | 210,942 | +19.8% | 0.00% | – |
| Q2 2022 | $1,230,000 | -57.1% | 176,101 | -7.1% | 0.00% | -100.0% |
| Q1 2022 | $2,867,000 | -29.1% | 189,611 | +2.9% | 0.00% | 0.0% |
| Q4 2021 | $4,044,000 | +3.3% | 184,299 | +27.0% | 0.00% | 0.0% |
| Q3 2021 | $3,915,000 | +157.1% | 145,154 | +129.6% | 0.00% | 0.0% |
| Q2 2021 | $1,523,000 | -39.4% | 63,220 | +9.1% | 0.00% | 0.0% |
| Q1 2021 | $2,515,000 | – | 57,967 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 4,007,413 | $89,004,643 | 3.76% |
| Opaleye Management Inc. | 330,000 | $7,329,300 | 2.55% |
| Deep Track Capital, LP | 2,656,901 | $59,009,771 | 2.48% |
| Eagle Health Investments LP | 437,911 | $9,726,003 | 2.24% |
| COMMODORE CAPITAL LP | 598,385 | $13,290 | 2.00% |
| Octagon Capital Advisors LP | 499,996 | $11,104,911 | 1.73% |
| Casdin Capital, LLC | 630,000 | $13,992,300 | 1.08% |
| Soleus Capital Management, L.P. | 254,700 | $5,656,887 | 0.81% |
| VIKING GLOBAL INVESTORS LP | 3,937,914 | $87,461,070 | 0.44% |
| Peloton Wealth Strategists | 37,000 | $822 | 0.40% |